Effective December 15, 2015, Michael Steinmetz, M.D., a Director of TetraLogic Pharmaceuticals Corporation, will resign from the Board of Directors of the Company due to health reasons. In his resignation letter, Dr. Steinmetz informed the company that he also intends to resign from other Boards of which he is a member.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.43K | |
-3.46% | 102B | |
+1.41% | 96.29B | |
+2.13% | 22.18B | |
-15.84% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.65% | 16.36B | |
+4.39% | 13.97B | |
+31.35% | 12.17B |
- Stock Market
- Equities
- TLOG Stock
- News TetraLogic Pharmaceuticals Corporation
- TetraLogic Pharmaceuticals Corporation Announces Resignation of Michael Steinmetz from the Board of Directors, Effective December 15, 2015